Showing results (1-10 of 389) with videos related to
Sort By:
Pageof 39
Pharmacology & Toxicology|April 1, 1995
Interaction between erythromycin and nitrazepam in healthy volunteersH Luurila, K T Olkkola, P J NeuvonenPharmacology & Toxicology|February 1, 1996
Interaction between erythromycin and the benzodiazepines diazepam and flunitrazepamH Luurila, K T Olkkola, P J NeuvonenTherapeutic Drug Monitoring|December 1, 1994
Lack of interaction of erythromycin with temazepamH Luurila, K T Olkkola, P J NeuvonenBritish Journal of Clinical Pharmacology|October 1, 1994
The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopicloneK Aranko, H Luurila, J T Backman, et al.Pharmacology & Toxicology|May 1, 1996
Pharmacokinetic-pharmacodynamic modelling of zopiclone effects on human central nervous systemH Luurila, K T OlkkolaClinical Pharmacology and Therapeutics|March 1, 1993
A potentially hazardous interaction between erythromycin and midazolamK T Olkkola, K Aranko, H Luurila, et al.British Journal of Clinical Pharmacology|November 1, 1984
Do gastric contents modify antidotal efficacy of oral activated charcoal?K T Olkkola, P J NeuvonenInternational Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1984
Effect of gastric pH on antidotal efficacy of activated charcoal in manK T Olkkola, P J NeuvonenEuropean Journal of Clinical Pharmacology|January 1, 1984
Effect of dose of charcoal on the absorption of disopyramide, indomethacin and trimethoprim by manP J Neuvonen, K T OlkkolaMedical Toxicology and Adverse Drug Experience|January 1, 1988
Oral activated charcoal in the treatment of intoxications. Role of single and repeated dosesP J Neuvonen, K T OlkkolaPageof 39